Pregled bibliografske jedinice broj: 40547
Structure-activity relationships of new antidotes in therapy of soman poisoning
Structure-activity relationships of new antidotes in therapy of soman poisoning // Proceedings of the CB Medical Treatment Symposium Industry I / Bokan, Slavko ; Orehovec, Zvonko (ur.).
Portland (ME): ASA, 1998. str. 276-279 (poster, međunarodna recenzija, cjeloviti rad (in extenso), znanstveni)
CROSBI ID: 40547 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Structure-activity relationships of new antidotes in therapy of soman poisoning
Autori
Radić, Božica ; Lucić, Ana ; Peraica, Maja
Vrsta, podvrsta i kategorija rada
Radovi u zbornicima skupova, cjeloviti rad (in extenso), znanstveni
Izvornik
Proceedings of the CB Medical Treatment Symposium Industry I
/ Bokan, Slavko ; Orehovec, Zvonko - Portland (ME) : ASA, 1998, 276-279
Skup
CB Medical Treatment Symposium Insdustry I - Eco-Terrorism Chemical and Biological Warfare without Chemical and Biological Weapons
Mjesto i datum
Dubrovnik, Hrvatska; Zagreb, Hrvatska, 25.10.1998. - 31.10.1998
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
soman; antidotes; quinuclidinium; imidazolium; oximes; AChE
Sažetak
This paper evaluates and compares antidotal characteristics of new antidotes with regard to their chemical structure. Tests were run on series of imidazolium, quinuclidinium, and pyridinium derivatives with different chains between rings and with different substituents on the rings. The activity of these compounds was determined in vitro on human erythrocyte acetylcholinesterase (AChE, EC 3.1.1.7) inhibited by Soman, and in vivo on Soman poisoned mice. We found that the length andthe type of the chain between rings and the type of substituent on the rings significantly influence the in vitro affinity, acute toxicity, and in vivo effectiveness of these antidotes. Imidazolium and pyridinium compounds demonstrated mostly weak reactivating and protective characteristics both in vitro and in vivo. All tested quinuclidinium derivatives were not effective in vitro. However, these compounds were effective in vivo, which indicates that the mechanism of their activity does not involve reactivation and/or protection of AChE in the nervous system.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
00220105
Ustanove:
Institut za medicinska istraživanja i medicinu rada, Zagreb